Next, WCUP administration prevented increases in serum IL-6 levels and muscular E3 ligase levels caused by CT-26 tumor burden (Fig. 3), resulting in the recovery of skeletal muscle mass and lean body mass. The gene discussed is IL6; the disease is neoplasm.